Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Ilaria, Portarena"'
Autor:
Silvia Riondino, Vincenzo Formica, Elena Valenzi, Cristina Morelli, Valeria Flaminio, Ilaria Portarena, Francesco Torino, Mario Roselli
Publikováno v:
Current Oncology, Vol 30, Iss 1, Pp 1220-1231 (2023)
Background: Aromatase inhibitors (AI) are widely used for treating hormone-sensitive breast cancer (BC). Obesity, however, due to aromatase-mediated androgen conversion into estradiol in the peripheral adipose tissue, might impair AI inhibitory capac
Externí odkaz:
https://doaj.org/article/710140592e9c4a799d00a6c215e557d7
Autor:
Ombretta Melaiu, Gianluca Vanni, Ilaria Portarena, Chiara Adriana Pistolese, Lucia Anemona, Silvia Pomella, Roberto Bei, Oreste Claudio Buonomo, Mario Roselli, Alessandro Mauriello, Giovanni Barillari
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 4, p 3226 (2023)
Immune checkpoint inhibitors (ICIs) have a modest clinical activity when administered as monotherapy against breast cancer (BC), the most common malignancy in women. Novel combinatorial strategies are currently being investigated to overcome resistan
Externí odkaz:
https://doaj.org/article/7387e27fbeb84922aef7b209c0686068
Autor:
Andrea Botticelli, Agnese Fabbri, Michela Roberto, Daniele Alesini, Alessio Cirillo, Giuliana D’Auria, Eriseld Krasniqi, Eleonora Marrucci, Margherita Muratore, Francesco Pantano, Laura Pizzuti, Ilaria Portarena, Rosalina Rossi, Simone Scagnoli, Paolo Marchetti
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
The recent addition of cyclin-dependent kinase 4 (CDK4) and CDK6 inhibitors to endocrine therapy has remarkably improved the outcome of patients affected with hormone receptor positive (HR+), human epidermal grow factor receptor 2 negative (HER2 -) a
Externí odkaz:
https://doaj.org/article/d76b983b99da478b9b49de9ccce936c1
Autor:
Gianluca Vanni, Marco Pellicciaro, Marco Materazzo, Giada Iafrate, Jonathan Caspi, Roberto Fiorito, Ilaria Portarena, Francesca Servadei, Erica Giacobbi, Lucia Anemona, Oreste Claudio Buonomo
Publikováno v:
PLASTIC RECONSTRUCTIVE & REGENERATIVE SURGERY. 1:92-97
Autor:
Rosaria Meucci, Adriana Pistolese Chiara, Tommaso Perretta, Gianluca Vanni, Ilaria Portarena, Guglielmo Manenti, Patricia Ryan Colleen, Antonella Castrignanò, Carla Di Stefano, Donatella Ferrari, Feliciana Lamacchia, Marco Pellicciaro, Marco Materazzo, Claudio Buonomo Oreste
Publikováno v:
European Journal of Radiology Open, Vol 7, Iss , Pp 100244- (2020)
Background: Magnetic Resonance(MR) guided percutaneous procedures(MRgVABB) have been developed and largely employed to reduce the need of surgical biopsies for suspicious lesions which can be detected only by MR(MR-only lesion). The present study aim
Externí odkaz:
https://doaj.org/article/e9ce940d7d79470aae305065ccf9536a
Autor:
Gianluca, Vanni, Marco, Pellicciaro, Marco, Materazzo, Jonathan, Caspi, Marcello, Chiocchi, Federico, Tacconi, Annalisa, Noce, Gianluca, Nicolai, Ilaria, Portarena, Chiara, Buonomo, Dauri, Mario, Oreste Claudio, Buonomo
Publikováno v:
Anticancer Research. 42:4913-4919
SARS-CoV-2 with a dramatical worldwide spread, impacted greatly daily life and healthcare. In order to avoid delay in cancer treatment, many strategies and measures were implemented. The Awake breast surgery was a strategy implemented in our Unit dur
Autor:
Marcello Chiocchi, Martina Cerocchi, Federica Di Tosto, Roberto Rosenfeld, Monia Pasqualetto, Gianluca Vanni, Vincenzo De Stasio, Luca Pugliese, Carlo Di Donna, Gaetano Idone, Saverio Muscoli, Ilaria Portarena, Mario Roselli, Francesco Garaci, Roberto Floris
Publikováno v:
Journal of Personalized Medicine
Volume 13
Issue 2
Pages: 199
Volume 13
Issue 2
Pages: 199
Breast cancer patients undergoing neoadjuvant chemotherapy with anthracyclines or trastuzumab can suffer cardiotoxic issues. Nowadays, the markers of cardiac damage are still not reliable, and extracellular volume (ECV) calculated from CT could be a
Autor:
Ilaria Portarena, Gianluca Vanni, Stefano Rizza, Tommaso Perretta, Marco Pellicciaro, Chiara Adriana Pistolese, Oreste Claudio Buonomo, Domiziana Pedini, Chiara Buonomo, Marco Materazzo
Publikováno v:
Anticancer Research. 41:2689-2696
BACKGROUND/AIM: The COVID-19 lockdown includes restrictive measures and temporary health system reorganization. Resources were shifted to COVID-19 patients, screening programs were temporary suspended, and oncological care suffered slow-down. The aim
Autor:
Oreste Claudio Buonomo, Emanuele Caredda, Ilaria Portarena, Gianluca Vanni, Augusto Orlandi, Claudia Bagni, Giuseppe Petrella, Leonardo Palombi, Paolo Orsaria
Publikováno v:
PLoS ONE, Vol 12, Iss 9, p e0184680 (2017)
Despite advances in treatment, up to 30% of patients with early breast cancer (BC) experience distant disease relapse. However, a comprehensive understanding of tumor spread and site-specific recurrence patterns remains lacking. This retrospective ca
Externí odkaz:
https://doaj.org/article/12c6c0a103844eeab2ee8cbb21f334d2
Autor:
Francesca Servadei, Rolando Maria D'Angelillo, Gianluca Vanni, Mario Dauri, Alessandro Mauriello, Chiara Adriana Pistolese, Marco Pellicciaro, Oreste Claudio Buonomo, Ilaria Portarena, Marco Materazzo, Erica Giacobbi, Agostino Chiaravalloti, Chiara Buonomo, Adriano De Majo
Publikováno v:
Breast Cancer
Breast Cancer (Tokyo, Japan)
Breast Cancer (Tokyo, Japan)
Introduction COVID-19 is a declared worldwide pandemic. In our country, due to shortage of hospitals and beds in intensive care unit, oncological and breast cancer (BC) resources are temporarily shifted to COVID-19 patients. In addition, risk of cros